Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables
The drug major also plans to utilise the capital for adding capacities to existing plants, firm up R&D activities and further…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.